XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (3,207,701) $ (3,539,782)
Adjustments for:    
Depreciation and amortization 67,618 90,428
Share-based compensation 147,836 334,053
Gain on loan forgiveness 0 (14,766)
Changes in working capital items:    
Accounts and other receivable (128,563) (484,110)
Prepaid expenses and other current assets 76,727 237,967
Accounts payable and accrued liabilities (856,418) 309,523
Net cash used in operating activities (3,900,501) (3,066,687)
Cash flows from financing activities:    
Proceeds from issuance of common shares and warrants 7,497,133 590,966
Proceeds from issuance of Series A-1 preferred shares and warrants 1,540,820 0
Payment for issuance costs of warrants (23,446) 0
Repayment of debt 0 (29,532)
Net cash provided by financing activities 16,844,415 517,441
Effect of exchange rate changes on cash and cash equivalents (84,584) (12,520)
Net change in cash and cash equivalents 12,859,330 (2,561,766)
Cash and cash equivalents, beginning of period 1,037,320 5,361,397
Cash and cash equivalents, end of period 13,896,650 2,799,631
Series B-1 Preferred Stock [Member]    
Cash flows from financing activities:    
Proceeds from issuance of Series B-1 preferred shares 8,340,000 0
Common Stock and Warrants [Member]    
Cash flows from financing activities:    
Payments for issuance costs (294,935) (43,993)
Preferred Stock [Member]    
Cash flows from financing activities:    
Payments for issuance costs $ (215,157) $ 0